We received reports of contacts from non-authorized operators claiming to act on our behalf. We would like to remind that MZ Congressi is the only authorized contact point for any matter related to this meeting. Anyway, to increase privacy of our speakers, we have removed e-mail addresses from the website.

Ulf Lindahl

Department of Medical Biochemistry and Microbiology,

Uppsala University, The Biomedical Center,

Uppsala, Sweden

Jian Liu

Division of Chemical Biology & Medicinal Chemistry,

Eshelman School of Pharmacy, University of North Carolina,

Chapel Hill, NC, USA

Yan Liu

Institute for Reproductive and Developmental Biology,

Imperial College London

London, UK

 Hugues Lortat-Jacob

Institut de Biologie Structurale, Centre National de la Recherche Scientifique,

CEA, Université Grenoble-Alpes,

Grenoble, France

Vladimir Lupashin

Department of Physiology and Biophysics,

College of Medicine

University of Arkansas for Medical Sciences,

Little Rock, AR, USA

John L. Magnani

Chief Science Officer and Senior V.P.

GlycoMimetics, Inc.

Rockville, MD, USA

Jamey Marth

Center for Nanomedicine,

University of California Santa Barbara,

Santa Barbara, CA, USA

Gert Matthijs

Center for Human Genetics,

KU Leuven,

Leuven, Belgium

Satyajit Mayor

National Centre for Biological Sciences,

Bangalore, India

Michael P. McDonald

Depts. of Neurology and Anatomy & Neurobiology

Director of Alzheimer Research

Memphis, TN, USA

Francesca Micoli

GSK Vaccines Institute for Global Health (GVGH) S.r.l.

Siena, Italy

Taeko Miyagi

Miyagi Cancer Center Research Institute

Sendai, Japan

Eiji Miyoshi

Osaka University Medical School,

Osaka, Japan

Antonio Molinaro

Department of Chemical Sciences and

Task Force on Microbiome Studies,

University of Naples Federico II,

Naples, Italy

Vincent Monnier

Case Western Reserve University,

Cleveland, Ohio, USA

Manuel Muniz

Department of Cell Biology,

University of Seville,

Seville, Spain

Tatsuro Mutoh

Department of Neurology & Neuroscience,

Fujita Health University School of Medicine,

Toyoake, Japan

Laurence Mulard

Chemistry of Biomolecules Laboratory and

CNRS UMR3523,

Institut Pasteur,

Paris, France

Hitoshi Nakayama

Associate Professor

Juntendo University Faculty of Health Care and Nursing

Hisashi Narimatsu

RCMG Inc. and

AIST, Japan

Jérôme Nigou

Département “Tuberculose & Biologie des Infections”

Institut de Pharmacologie et de Biologie Structurale

UMR 5089 CNRS – Université de Toulouse

Toulouse, France

Shoko Nishihara

Laboratory of Cell Biology, Department of Bioinformatics,

Graduate School of Engineering, Soka University,

Hachioji, Japan

Barry R. O’Keefe

Acting Chief, Molecular Targets Program

Center for Cancer Research

Chief, Natural Products Branch, Developmental Therapeutics Program

Division of Cancer Treatment and Diagnosis

National Cancer Institute

Frederick, MD, USA

Nicki Packer

Department of Molecular Sciences, Macquarie University,

Institute for Glycomics, Griffith University

Australia

Katharina Paschinger

Department für Chemie, Universität für Bodenkultur,

Vienna, Austria

James C. Paulson

Department of Molecular Medicine,

The Scripps Research Institute,

La Jolla, CA, USA

Li Peng

SVP of Discovery and Early Product Development,

Palleon Pharmaceuticals,

Waltham, MA, USA

Claney L. Pereira

Managing Director and Director of Chemistry

Vaxxilon Deutschland GmbH

Berlin, Germany

Fabian Pfrengle

Max Planck Institute of Colloids and Interfaces,

Potsdam, Germany

Alexey V. Pshezhetsky

Sainte-Justine Hospital Research Center,

University of Montreal,

McGill University, Department of Anatomy and Cell Biology,

Montreal, CANADA

Naila Rabbani

University of Warwick,

Coventry, U.K.

Celso Albuquerque Reis

Head of the Glycobiology in Cancer Group

IPATIMUP – Institute of Molecular Pathology and Immunology of the University of Porto

Porto, Portugal

Shifang Ren

NHC Key Laboratory of Glycoconjugates Research,

Department of Biochemistry and Molecular Biology,

School of Basic Medical Sciences,

Fudan University,

Shanghai, China

Yuanyuan Ruan 

Department of Biochemistry and Molecular Biology,

Fudan University,

Shanghai, China

Konrad Sandhoff

LIMES Institute, Membrane Biology & Lipid Biochemistry Unit,

Kekulé-Institut für Organische Chemie und Biochemie,

Universität Bonn,

Bonn, Germany

Chihiro Sato

Bioscience and Biotechnology Center,

Nagoya University,

Chikusa, Nagoya, Japan

Nichollas E. Scott

Department of Microbiology and Immunology

University of Melbourne

Melbourne, Australia

Marcello Sega

Forschungszentrum Jülich GmbH

Helmholtz-Institut Erlangen-Nürnberg

Nürnberg, Deutschland

Liana C. Silva
iMed.ULisboa – Research Institute for Medicines,

Faculdade de Farmácia, Universidade de Lisboa,

Lisboa, Portugal

Atsushi Shimoyama

Department of Chemistry, School of Science,

Osaka University

Osaka, Japan

Thomas Simmen

Department of Cell Biology, University of Alberta,

Edmonton, Canada

Simonetta Sipione

Department of Pharmacology and

Neuroscience and Mental Health Institute,

University of Alberta,

Edmonton, AB, Canada

Sandro Sonnino

Department of Medical Biotechnology and Translational Medicine

University of Milano,

Milano, Italy

Richard Strasser

BOKU

Vienna, Austria

Avadhesha Surolia

Bhatnagar Fellow, Council of Scientific & Industrial Research (CSIR),

Honorary Professor, Molecular Biophysics Unit

Indian Institute of Science,

Bangalore, India

Akemi Suzuki

Tohoku Medical and Pharmaceutical University,

Sendai, Japan

Kenichi G.N. Suzuki

Institute for Integrated Cell-Material Sciences (WPI-iCeMS),

Kyoto University

Kyoto, Japan;

Center for Highly Advanced Integration of Nano and Life Sciences (G-CHAIN),

Gifu University

Gifu, Japan

Tomohiko Taguchi

Laboratory of Organelle Pathophysiology,

Department of Integrative Life Sciences,

Graduate School of Life Sciences, Tohoku University

Sendai, Japan

 Naoyuki Taniguchi

Department of Glyco-Oncology and Medical Biochemistry,

Osaka International Cancer Institute,

Osaka, Japan

Paul J. Thornalley

Director, Diabetes Research Center, Qatar Biomedical Research Institute (QBRI),

Hamad Bin Khalifa University, Qatar Foundation

Doha, Qatar

President, International Maillard Reaction Society (IMARS) & Chair,

European Association for the Study of Diabetes (EASD)

Reactive Metabolites Study Group (RMSG)

Els van Damme

Department of Biotechnology, Ghent University,

Ghent, Belgium

Sandra J. van Vliet

Department of Molecular Cell Biology and Immunology

Amsterdam UMC

Amsterdam, The Netherlands

David J. Vocadlo

Department of Chemistry

and Department of Molecular Biology and Biochemistry,

Simon Fraser University,

Burnaby, BC, Canada

Mark von Itzstein

Institute for Glycomics, Griffith University,

Gold Coast Campus, Australia

George Peng Wang

Department of Chemistry, Georgia State University,

Atlanta, GA, USA

Shih-Hsiung Wu

Institute of Biological Chemistry,

Academia Sinica, Taiwan

Peng Wu

Department of Molecular Medicine

The Scripps Research Institute

La Jolla, CA, USA

Manfred Wuhrer

Center for Proteomics and Metabolomics,

Leiden University Medical Center

Netherlands

Sho Yamasaki

Molecular Immunology,

Research Institute for Microbial Diseases (RIMD)

Immunology Frontier Research Center (IFReC)

Osaka University

Suita, Japan

Natasha Zachara

Department of Biological Chemistry,

The Johns Hopkins University School of Medicine,

Baltimore, MD, USA

Thomas Zemb

Institut de Chimie Separative de Marcoule (ISCM)

CEA Marcoule

Bagnols-sur-Cèze, France

Chiara Zurzolo

Unité de Trafic Membranaire et Pathogénèse,

Institut Pasteur,

Paris, France